Literature DB >> 19585772

Recovery of multidrug-resistant bacteria from combat personnel evacuated from Iraq and Afghanistan at a single military treatment facility.

Clinton K Murray1, Heather C Yun, Matthew E Griffith, Bernadette Thompson, Helen K Crouch, Linda S Monson, Wade K Aldous, Katrin Mende, Duane R Hospenthal.   

Abstract

U.S. combat casualties from Iraq and Afghanistan continue to develop infections with multidrug-resistant (MDR) bacteria. This study assesses the infection control database and clinical microbiology antibiograms at a single site from 2005 to 2007, a period when all Operation Iraqi Freedom (OIF)/Operation Enduring Freedom (OEF) casualties admitted to the facility underwent initial isolation and screening for MDR pathogens. During this 3-year period, there were 2,242 OIF/OEF admissions: 560 in 2005, 724 in 2006, and 958 in 2007. The most commonly recovered pathogens from OIF/OEF admission screening cultures were methicillin-resistant Staphylococcus aureus (MRSA), Klebsiella pneumoniae and Acinetobacter. The yearly nosocomial infection rate of these three pathogens among OIF/OEF admissions ranged between 2 and 4%. There were remarkable changes in resistance profiles for Acinetobacter, K. pneumoniae, and S. aureus over time. Despite aggressive infection control procedures, there is continued nosocomial transmission within the facility and increasing antimicrobial resistance in some pathogens. Novel techniques are needed to control the impact of MDR bacteria in medical facilities.

Entities:  

Mesh:

Year:  2009        PMID: 19585772     DOI: 10.7205/milmed-d-03-8008

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  27 in total

1.  In vitro characterization of multivalent adhesion molecule 7-based inhibition of multidrug-resistant bacteria isolated from wounded military personnel.

Authors:  Anne Marie Krachler; Katrin Mende; Clinton Murray; Kim Orth
Journal:  Virulence       Date:  2012-06-22       Impact factor: 5.882

Review 2.  Infection in conflict wounded.

Authors:  W G P Eardley; K V Brown; T J Bonner; A D Green; J C Clasper
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-01-27       Impact factor: 6.237

3.  Culture-independent pilot study of microbiota colonizing open fractures and association with severity, mechanism, location, and complication from presentation to early outpatient follow-up.

Authors:  Geoffrey D Hannigan; Brendan P Hodkinson; Kelly McGinnis; Amanda S Tyldsley; Jason B Anari; Annamarie D Horan; Elizabeth A Grice; Samir Mehta
Journal:  J Orthop Res       Date:  2014-01-03       Impact factor: 3.494

Review 4.  Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.

Authors:  Darren Wong; Travis B Nielsen; Robert A Bonomo; Paul Pantapalangkoor; Brian Luna; Brad Spellberg
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

5.  Molecular epidemiology and characterization of multiple drug-resistant (MDR) clinical isolates of Acinetobacter baumannii.

Authors:  Sherief El-Shazly; Ali Dashti; Leila Vali; Michael Bolaris; Ashraf S Ibrahim
Journal:  Int J Infect Dis       Date:  2015-10-27       Impact factor: 3.623

6.  Sublethal concentrations of carbapenems alter cell morphology and genomic expression of Klebsiella pneumoniae biofilms.

Authors:  Tricia A Van Laar; Tsute Chen; Tao You; Kai P Leung
Journal:  Antimicrob Agents Chemother       Date:  2015-01-12       Impact factor: 5.191

7.  Genotyping of methicillin-resistant Staphylococcus aureus from sepsis patients in Pakistan and detection of antibodies against staphylococcal virulence factors.

Authors:  Stefan Monecke; Muhammad Ali Syed; Mushtaq Ahmad Khan; Shehzad Ahmed; Sadia Tabassum; Darius Gawlik; Elke Müller; Annett Reissig; Sascha D Braun; Ralf Ehricht
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-09-03       Impact factor: 3.267

8.  Do biofilm formation and interactions with human cells explain the clinical success of Acinetobacter baumannii?

Authors:  Anna de Breij; Lenie Dijkshoorn; Ellen Lagendijk; Joke van der Meer; Abraham Koster; Guido Bloemberg; Ron Wolterbeek; Peterhans van den Broek; Peter Nibbering
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

Review 9.  Code blue: Acinetobacter baumannii, a nosocomial pathogen with a role in the oral cavity.

Authors:  A M Richards; Y Abu Kwaik; R J Lamont
Journal:  Mol Oral Microbiol       Date:  2014-09-27       Impact factor: 3.563

10.  PRP as a new approach to prevent infection: preparation and in vitro antimicrobial properties of PRP.

Authors:  Hongshuai Li; Bingyun Li
Journal:  J Vis Exp       Date:  2013-04-09       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.